Advertisement Pfizer selects Pristima for Drug Safety R&D data management solution - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pfizer selects Pristima for Drug Safety R&D data management solution

Pfizer has selected Xybion's Pristima Suite to manage its global Drug Safety R&D (DSRD) data management operations.

Pristima is software as a service (SaaS) model that consolidates several systems and applications into a single, global solution.

As part of the deal, Pfizer will implement a suite of Pristima modules for DSRD data management and reporting of toxicology studies.

Licensed modules under the deal include the Pristima SEND module to support CDISC regulatory electronic data submission and Pristima Savante to aggregate, analyze and visualize data from a central data repository (CDR).

The deal will see Xybion provide a number of services for Pfizer’s implementation of Pristima, including the utilization of Xybion’s services to facilitate Pristima validation.

Pfizer might also leverage Xybion’s training and implementation services to train personnel and configure Pristima to meet Pfizer’s best practices and reporting specifications.

Xybion CEO Pradip Banerjee said the company is happy to welcome Pfizer to its client community and it is energized and excited to deliver on this global project.

"We recognize that Pfizer was a significant contributor to the requirements and conceptualization of Pristima, so it is extremely satisfying to see Pfizer has selected Pristima for its DSRD data management operations," Banerjee said.